Reata Pharmaceuticals, Inc. Pre-Tax Profit Margin 2016-2023 | RETA
Reata Pharmaceuticals, Inc. pre-tax profit margin from 2016 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-06-30 | $0.02B | $-0.09B | -366.67% |
| 2023-03-31 | $0.00B | $-0.36B | -17750.00% |
| 2022-12-31 | $0.00B | $-0.31B | -10433.33% |
| 2022-09-30 | $0.00B | $-0.31B | -7800.00% |
| 2022-06-30 | $0.01B | $-0.31B | -3050.00% |
| 2022-03-31 | $0.01B | $-0.30B | -2763.64% |
| 2021-12-31 | $0.01B | $-0.30B | -2700.00% |
| 2021-09-30 | $0.01B | $-0.28B | -2138.46% |
| 2021-06-30 | $0.01B | $-0.27B | -3885.71% |
| 2021-03-31 | $0.01B | $-0.27B | -3337.50% |
| 2020-12-31 | $0.01B | $-0.27B | -3387.50% |
| 2020-09-30 | $0.01B | $-0.39B | -4900.00% |
| 2020-06-30 | $0.02B | $-0.37B | -2440.00% |
| 2020-03-31 | $0.02B | $-0.33B | -1660.00% |
| 2019-12-31 | $0.03B | $-0.29B | -1074.07% |
| 2019-09-30 | $0.03B | $-0.13B | -403.13% |
| 2019-06-30 | $0.03B | $-0.12B | -413.79% |
| 2019-03-31 | $0.03B | $-0.11B | -393.10% |
| 2018-12-31 | $0.05B | $-0.08B | -152.83% |
| 2018-09-30 | $0.06B | $-0.07B | -130.91% |
| 2018-06-30 | $0.06B | $-0.05B | -84.13% |
| 2018-03-31 | $0.07B | $-0.04B | -54.41% |
| 2017-12-31 | $0.05B | $-0.05B | -97.96% |
| 2017-09-30 | $0.05B | $-0.04B | -67.31% |
| 2017-06-30 | $0.05B | $-0.02B | -46.15% |
| 2017-03-31 | $0.05B | $-0.01B | -25.49% |
| 2016-12-31 | $0.05B | $-0.01B | -12.00% |
| 2016-09-30 | $0.05B | $-0.00B | -6.00% |
| 2016-06-30 | $0.05B | $-0.00B | -4.00% |
| 2016-03-31 | $0.05B | $-0.00B | -4.00% |
| 2015-12-31 | $0.05B | $-0.00B | -1.96% |
